Hi there

Who we are

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Team

Greater perspectives create greater outcomes.

Balance, diversity and passion are at the core of who we are. Meet the hardworking people who defy convention, shatter glass ceilings, and take companies to the top—all with a unique style and a healthy dose of humor.

Companies

A dynamic
portfolio

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Companeis

The future looks bright.

Say hello to our extended family. An impressive roster of agile and imaginative companies that are building the future of healthcare and technology, one big idea at a time. Our portfolio of entrepreneurial muscle includes 59 IPOs and 134 M&As. And counting.

Approach

A hand
in every stage

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach

About

This is Canaan.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Hi there

Who we are

>Hermeus

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

More about us

Experience

A fine
balance

>The RealReal

The passion you want at your side, plus the experience you want at the table.

Meet Our Team

Companies

A dynamic
portfolio

>IDEAYA Biosciences

Across healthcare and technology, we partner with companies that improve lives.

See Our Companies

Approach

A hand
in every stage

>Berkshire Grey

From the first handshake to the final round, we do what it takes to bring your vision to life.

Learn About Our Approach
Highlight

Mobilizing the Immune System Against Solid Tumors

Canaan company, Rondo Therapeutics has dosed the first patient in a Phase 1 clinical trial evaluating RNDO-564, a novel bispecific antibody...
Highlight

Agent Economy: Darwin Is Running Your Next Board Meeting

The biggest threat to companies today isn’t incompetence—it’s comfort. As AI rapidly automates core business functions, the firms that move early...
Highlight

Aerospace Timelines Just Got a Little Shorter

Hermeus recently completed the first flight of its Quarterhorse Mk 2.1, marking its second successful first flight in just nine months—an unusually...
Highlight

Rapidata Is Shortening AI Development Cycles from Months to Days

Canaan company, Rapidata, enables AI teams to gather high-quality human feedback on demand from a global network of participants, compressing...